Adding paragraph (b)(7)
BPC-157 may actually reduce GI symptoms common with triple agonist therapy
Common side effects include injection site reactions, nausea, headache, and red-coloured urine
Switching to a compounded vial with manual reconstitution requires you to handle the mixing and measuring yourself
Most medical professionals will recommend alternate injection sites to avoid scarring and irritation
The results suggested that TB-500 not only potentially enhanced the viability, angiogenesis, and migratory ability of HUVEC but possibly also promoted the expression of angiopoietin-2 (Ang2), TEK receptor tyrosine kinase 2 (tie2), vascular endothelial growth factor A (VEGFA), NOTCH1 intracellular domain (N1ICD), Notch receptor 3 (Notch3), NF-B, and phosphorylated (p)-p65 in HUVEC